首页|动静脉体外膜肺氧合治疗难治性心源性休克患者的临床价值及预后研究

动静脉体外膜肺氧合治疗难治性心源性休克患者的临床价值及预后研究

Clinical value and prognosis of arteriovenous extracorporeal membrane oxygenation in patients with refractory cardiogenic shock

扫码查看
目的:探讨动静脉体外膜肺氧合(VA-ECMO)支持治疗难治性心源性休克(RCS)患者的临床应用价值及其预后影响因素.方法:回顾性分析2022年1月-2023年4月于我院因RCS接受VA-ECMO行辅助治疗94例患者的临床资料,分析VA-ECMO辅助治疗前、后超声心动图参数变化,根据VA-ECMO撤机成功与否将其分为成功组(73例)和失败组(21例),比较两组患者一般资料、血流动力学及生化指标结果,分析影响患者脱机的独立风险因素.结果:①不同病因间左室每搏量(LVSV)、左室射血分数(LVEF)、二尖瓣侧壁瓣环收缩速度(Sa)、主动脉瓣口前向血流速度(AV)、速度-时间积分(VTI)差异具有统计学意义(均P<0.05).与急性心肌缺血(AMI)组比较,暴发性心肌炎(FM)组、原发性心源性休克(CS)组的LVSV、LVEF、VTI测值更低(均P<0.05).②94例患者中73例患者成功撤机,21例撤机失败,成功组ECMO辅助时间明显小于失败组(P<0.05).③与ECMO建立前比较,成功组与失败组建立后的心率(HR)、LVESV、E/e'、血红蛋白(HGB)、血小板(PLT)及谷氨酸氨基转移酶(ALT)、LVSV、LVEF、三尖瓣瓣环收缩速度(S')、Sa、AV、VTI、TAPSE、C反应蛋白(CRP)、血白细胞(WBC)存在组间差异(均P<0.05).与失败组比较,成功组在ECMO建立前、后血乳酸(Lac)、WBC、尿素/血肌酐(Urea/Crea)、休克指数(SI)、D-二聚体(D-dimer)、CRP、天冬氨酸氨基转移酶(AST)、ALT、PLT存在组间差异(均P<0.05).④多因素logistic回归分析结果显示S'、Lac、AST、ALT、Urea/Crea是影响RCS患者脱机成功的影响因素.结论:VA-ECMO治疗可显著改善RCS患者心脏功能,S'、Lac、AST、ALT、Urea/Crea是脱机成功的影响因素.
Objective:To investigate the clinical value and prognostic factors of arteriovenous extracorporeal membrane oxygenation(VA-ECMO)support for the treatment of patients with refractory cardiogenic shock.Methods:We retrospectively analyzed the clinical data of 94 patients who underwent VA-ECMO assisted treatment for refractory cardiogenic shock from January 2022 to April 2023,analyzed the changes of echocardiographic pa-rameters of the patients before and after VA-ECMO assisted treatment,and classified them into the success group(73 cases)and the failure group(21 cases)according to the success of the withdrawal of VA-ECMO,and com-pared the general data,hemodynamic and biochemical parameters of the patients in the two groups,and analyze the independent risk factors affecting the clinical outcomes of patients.Results:①There were significant differ-ences in left ventricular stroke volume(LVSV),left ventricular ejection fraction(LVEF),mitral annulus systolic velocity(Sa),aortic valve orifice forward flow velocity(AV)and velocity-time integral(VTI)among different etio-logical groups(all P<0.05).Compared with the acute myocardial ischemia(AMI)group,the LVSV,LVEF,and VTI measurements were lower in the fulminant myocarditis(FM)group and the primary cardiogenic shock(CS)group(all P<0.05).②Among the 94 patients,73 patients were weaned successfully and 21 patients failed.The time of ECMO assistance in the success group was significantly shorter than that in the failure group(P<0.05).③Compared with before ECMO,heart rate(HR),LVESV,E/e',hemoglobin(HGB),platelets(PLT),and glu-tamate aminotransferase(ALT),LVSV,LVEF,tricuspid annulus peak systolic velocity(S'),Sa,AV,VTI,TAPSE,and C-reactive protein(CRP)and white blood cells(WBC)were significantly different between successful group and failed group(all P<0.05).Compared with the failure group,there were significant differences in lac-tate(Lac),WBC,Urea/Crea,shock index(SI),D-dimer,CRP,aspartate aminotransferase(AST),ALT and PLT before and after ECMO in the success group(all P<0.05).④Multivariate logistic regression analysis showed that S',Lac,AST,ALT and Urea/Crea were the influencing factors of weaning success in patients with refractory cardiogenic shock.Conclusion:VA-ECMO treatment can significantly improve cardiac function in pa-tients with refractory cardiogenic shock.The dynamic evaluations of S',Lac,AST,ALT and Urea/Crea have certain value for the prognosis of patients.

extracorporeal membrane oxygenationrefractory cardiogenic shockechocardiographyveno-ar-terial extracorporeal membrane oxygenation

赵倩、张艳、乔荞、邓爱云

展开 >

兰州大学第一临床医学院(兰州 730000)

兰州大学第一医院心内超声室

体外膜肺氧合 难治性心源性休克 超声心动图 动静脉体外膜肺氧合

甘肃省科技厅自然科学基金

22JR5RA933

2024

临床心血管病杂志
华中科技大学心血管病研究所 华中科技大学协和医院

临床心血管病杂志

CSTPCD
影响因子:0.653
ISSN:1001-1439
年,卷(期):2024.40(2)
  • 37